Back
 

View:
Mini 
BasicThis view is available after user registration.
 
ShortThis view is available when you buy a license.
 
StandardThis view is available when you buy a license.
 
CompleteThis view is available when you buy a license.
 

Obinutuzumab 1000 / Venetoclax (50/100/200/400), Chronic Lymphocytic Leukemia, cycle 2, first line

Protocol-ID: 1316 V2.0 (Mini), OBIN1000/VNTC(50/100/200/400), CLL, C2, first-line

Indication(s)

  • Chronic Lymphocytic Leukemia / Small Lymphocytic Lymphoma; ICD-10 C91.1-
The publishers and authors assume no liability for the accuracy of the contents. The application is at the own responsibility of the treating physician. ©Onkopti.

Valid since: 04.08.2020